Lv0
0 积分 2023-10-16 加入
Predicting cancer outcomes from histology and genomics using convolutional networks
15天前
已完结
Correlation of Histologic Subtypes and Molecular Alterations in Pulmonary Adenocarcinoma: Therapeutic and Prognostic Implications
15天前
已完结
Resistance to BRAF-targeted therapy in melanoma
1个月前
已完结
The future of immune checkpoint therapy
1个月前
已完结
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
1个月前
已完结
Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial
1个月前
已完结
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial
1个月前
已完结
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin
1个月前
已完结
Intratumor Heterogeneity and Branched Evolution
1个月前
已完结
Explainable artificial intelligence for multi-modal cancer analysis: From genomics to immunology
1个月前
已完结
皖公网安备34019202002308
